Components of Hib Vaccine	Excipients Table Allergens Table Components Table
Indication Induction of active immunity against invasive diseases caused by encapsulated Haemophilus influenzae type b Proprietary Name HibTITTER PedvaxHIB ActHIB/OmniHIB Manufacturers Wyeth-Lederly Merck sanofi pasteur/ GlaxoSmithKline Viability Inactivated Inactivated Inactivated Microorganism Haemophilus influenzae Corynebacterium diptheriae H. influenza Neisseria meningitidis H. influenza (tetanus toxoid conjugate) Dose 0.5 mL 0.5 mL 0.5 mL Route Intramuscular Intramuscular Intramuscular Dosage form Solution Suspension Powder for solution Appearance Clear, Colorless Slightly opaque white Clear, Colorless after mixing Concentration (per 0.5 mL) Haemophilus b saccharide, 10 mcg Haemophilus b PRP, 7.5 mcg Neisseria meningitides OMPC, 125 mcg Aluminum hydrosyphosphate sulfate, 225 mcg Sodium chloride, 0.9% Polysaccharide, 10 mcg Preservatives None None None Adjuvant CRM197 protein, 25 mcg N.meningitidis OMP125 Aluminium hydoxide, 225 mcg Tetanus toxoid, 24 mcg Excipients None None 8.5% sucrose, Ammonium sulfate Formalin Allergens None None None Media Casamino acids Yeast Extract Complex fermentation Semisynthetic Packaging Vial, 1 Dose (5 per package) Box of 10 single-dose vials Box of 5 single dose vials packaged with diluent Routine Storage 2 to 8° C (36-46° F) Do Not Freeze 2 to 8° C (36-46° F) Do Not Freeze 2 to 8° C (36-46° F) Do Not Freeze updated July 2005
This page was last updated on January 23, 2008 © 2005 Institute for Vaccine Safety